Frequency: The dosing frequency depends on the indication
Detection of BPC-157 would require submission to a specialized LC-MS/MS lab with a validated method
Across approximately 900 participants, the adverse event profile was indistinguishable from placebo
Cortagen targets the cerebral cortex and may support neurological function in lupus patients who experience neuropsychiatric symptoms, a feature present in up to 75% of SLE patients at some point in their disease course
Nature 380:435439 Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS et al (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis